The global spine biologics market is forecasted to grow at a compound annual growth rate of 4.09 percent between 2018 and 2022, according to a Technavio report.
Here are three things to know:
1. A growing geriatric population will propel the market.
2. A key market trend is the increasing adoption of minimally invasive surgical procedures.
3. Key vendors include:
- Alphatec Spine
- Globus Medical
- Medtronic
- NuVasive
More articles on biologics:
DiscGenics treats 1st patient in degenerative disc disease clinical trial: 5 things to know
3 things to know about Organogenesis
Study: Single-injection durolane hylauronic acid safe, effective treatment for knee osteoarthritis